NeuroStar and Nexstim represent two different approaches to targeting the prefrontal cortex. NeuroStar uses the established 5-cm rule — measuring from the motor cortex to find the treatment target. Nexstim adds MRI-based neuronavigation to create a personalized targeting map for each patient. The question is whether that precision matters enough to justify the added complexity and cost.
What You’ll Learn
- How standard targeting (NeuroStar) compares to navigated targeting (Nexstim)
- When neuronavigation may offer real clinical advantages
- US availability for each system
- Insurance and cost considerations
Targeting Methods
NeuroStar uses the motor threshold method: locate the motor cortex (where hand movement is triggered by stimulation), measure 5 cm forward, and that’s the treatment target. It’s reliable, well-validated, and has been the standard since the FDA’s 2008 clearance. The 5-cm rule works well for most patients.
Nexstim uses MRI-based neuronavigation. Before treatment, the system creates a 3D model of the patient’s brain and maps the optimal target based on individual anatomy. The coil position is tracked in real time, ensuring consistent placement across sessions.
The precision advantage is real. Studies suggest individual anatomy can shift the optimal target by 1-2 cm from the anatomical landmark. Navigation eliminates that guesswork.
When Navigation Matters
For most patients with standard depression, the 5-cm rule produces good outcomes. The precision advantage of navigation is most meaningful for:
- Patients with atypical brain anatomy (from prior surgery, stroke, or congenital variation)
- Patients who didn’t respond well to a first TMS course on a standard system
- Clinical trials and research protocols requiring precise targeting
For typical treatment-resistant depression without anatomical complications, the navigation advantage is theoretical more than practical. The outcomes data for standard TMS is strong enough that most patients don’t need navigation to get good results.
US Availability and Cost
Nexstim has a smaller US footprint than NeuroStar. The system is more commonly found at academic medical centers and specialized neuromodulation clinics. Finding a Nexstim provider requires specific searching.
The added complexity of MRI-based navigation typically means higher cost. Insurance coverage is less well-established for navigated TMS than for standard NeuroStar protocols. Your clinic’s billing department can clarify what’s covered under your plan.
The Bottom Line
For most patients starting TMS for depression, NeuroStar is the practical choice: widely available, well-covered by insurance, and backed by extensive clinical data.
Nexstim is a reasonable option if you have anatomical considerations, didn’t respond to standard TMS, or are treated at an academic center that uses it. The targeting precision is a genuine advantage — it’s just not necessary for most patients.
Search for TMS providers or explore other device comparisons.
Key Takeaways
- NeuroStar uses the established 5-cm rule for targeting
- Nexstim adds MRI-based neuronavigation for personalized targeting
- For most patients, standard targeting produces equivalent outcomes
- Nexstim may benefit patients with atypical anatomy or prior non-response
- NeuroStar is more widely available and better covered by insurance
Find a TMS Clinic
Browse verified TMS providers and filter by device type.